H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Microbiology D-index 52 Citations 12,393 203 World Ranking 1849 National Ranking 120

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Immune system
  • Cancer

Margot Zöller spends much of her time researching CD44, Cell biology, Cancer research, Immunology and Microvesicles. Her work carried out in the field of CD44 brings together such families of science as Molecular biology, Metastasis, Extracellular matrix, Antibody and Gene isoform. She has included themes like T cell and CD151 in her Cell biology study.

Her Angiogenesis study in the realm of Cancer research connects with subjects such as Oxidoreductase complex. Her Immunology research is multidisciplinary, incorporating elements of Lamina propria and Cancer stem cell. Her research integrates issues of Fibronectin, Cell culture and Tetraspanin in her study of Microvesicles.

Her most cited work include:

  • A NEW VARIANT OF GLYCOPROTEIN CD44 CONFERS METASTATIC POTENTIAL TO RAT CARCINOMA CELLS (1504 citations)
  • CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? (749 citations)
  • Tetraspanins: push and pull in suppressing and promoting metastasis (477 citations)

What are the main themes of her work throughout her whole career to date?

Her primary scientific interests are in Immunology, Cancer research, CD44, Cell biology and Molecular biology. Her Immunology study frequently involves adjacent topics like Cytotoxic T cell. Her biological study spans a wide range of topics, including Tumor progression, Metastasis, Pancreatic cancer and Bone marrow.

Her work in CD44 addresses issues such as Pathology, which are connected to fields such as Colorectal cancer. She combines subjects such as Microvesicles, Tetraspanin and Cell adhesion with her study of Cell biology. Her research investigates the connection between Molecular biology and topics such as In vivo that intersect with issues in In vitro.

She most often published in these fields:

  • Immunology (62.31%)
  • Cancer research (37.39%)
  • CD44 (37.69%)

What were the highlights of her more recent work (between 2012-2021)?

  • Cancer research (37.39%)
  • Microvesicles (13.65%)
  • Cell biology (32.64%)

In recent papers she was focusing on the following fields of study:

Cancer research, Microvesicles, Cell biology, Exosome and Metastasis are her primary areas of study. Her Cancer research research is multidisciplinary, relying on both Cancer, Cancer stem cell, Tumor progression, Integrin and Bone marrow. Her Microvesicles research includes elements of Stromal cell, Angiogenesis, Wound healing, Immunology and Tetraspanin.

Her Cell biology study integrates concerns from other disciplines, such as Cell, CD44 and Transcription factor. Her CD44 research integrates issues from Ex vivo, Fibronectin, Cell adhesion, Cell adhesion molecule and Leukemia. Her study focuses on the intersection of Exosome and fields such as Pancreatic cancer with connections in the field of Pathology.

Between 2012 and 2021, her most popular works were:

  • Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity. (260 citations)
  • Exosomal tumor microRNA modulates premetastatic organ cells. (240 citations)
  • Exosomal tumor microRNA modulates premetastatic organ cells. (240 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Cancer

Her primary areas of investigation include Microvesicles, Cancer research, Exosome, Immunology and Cell biology. Her Microvesicles research incorporates elements of Stromal cell, CD44, Oncology, Cell adhesion and Cell adhesion molecule. The concepts of her CD44 study are interwoven with issues in Wound healing and Fibronectin, Extracellular matrix.

Her Cancer research study combines topics in areas such as Cell, CXCR4, CD151, Metastasis and Motility. Her studies in Exosome integrate themes in fields like TSPAN8, Internal medicine, Flow cytometry and Paca. The study incorporates disciplines such as Cancer stem cell and Angiogenesis in addition to Immunology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A NEW VARIANT OF GLYCOPROTEIN CD44 CONFERS METASTATIC POTENTIAL TO RAT CARCINOMA CELLS

Ursula Günthert;Martin Hofmann;Wolfgang Rudy;Sonja Reber.
Cell (1991)

2168 Citations

CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?

Margot Zöller.
Nature Reviews Cancer (2011)

1197 Citations

Tetraspanins: push and pull in suppressing and promoting metastasis

Margot Zöller.
Nature Reviews Cancer (2009)

754 Citations

CD44 in cancer progression: adhesion, migration and growth regulation.

R Marhaba;M Zöller;M Zöller.
Journal of Molecular Histology (2003)

553 Citations

Participation in normal immune responses of a metastasis-inducing splice variant of CD44

Robert Arch;Karin Wirth;Martin Hofmann;Helmut Ponta.
Science (1992)

541 Citations

Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation.

Irina Nazarenko;Sanyukta Rana;Alexandra Baumann;Jessica McAlear.
Cancer Research (2010)

539 Citations

Toward tailored exosomes: The exosomal tetraspanin web contributes to target cell selection

Sanyukta Rana;Shijing Yue;Daniela Stadel;Margot Zöller.
The International Journal of Biochemistry & Cell Biology (2012)

523 Citations

Prevention of tumor metastasis formation by anti-variant CD44.

S Seiter;R Arch;S Reber;D Komitowski.
Journal of Experimental Medicine (1993)

503 Citations

CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines.

Martin Hofmann;Wolfgang Rudy;Margot Zöller;Cornelia Tölg.
Cancer Research (1991)

453 Citations

Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity.

Bindhu Madhavan;Shijing Yue;Uwe Galli;Sanyukta Rana.
International Journal of Cancer (2015)

390 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Margot Zöller

Peter Herrlich

Peter Herrlich

Leibniz Association

Publications: 55

Helmut Ponta

Helmut Ponta

Karlsruhe Institute of Technology

Publications: 49

Jonathan P. Sleeman

Jonathan P. Sleeman

University Medical Centre Mannheim

Publications: 45

Hideyuki Saya

Hideyuki Saya

Keio University

Publications: 34

Ralf Paus

Ralf Paus

University of Miami

Publications: 29

Antonin de Fougerolles

Antonin de Fougerolles

Alnylam Pharmaceuticals (United States)

Publications: 26

Steven T. Pals

Steven T. Pals

University of Amsterdam

Publications: 25

Ron N. Apte

Ron N. Apte

Ben-Gurion University of the Negev

Publications: 25

Claude Boucheix

Claude Boucheix

Inserm : Institut national de la santé et de la recherche médicale

Publications: 23

Lilly Y. W. Bourguignon

Lilly Y. W. Bourguignon

San Francisco VA Medical Center

Publications: 23

Richard J. Simpson

Richard J. Simpson

La Trobe University

Publications: 22

Michael Ploug

Michael Ploug

University of Copenhagen

Publications: 21

Eric Rubinstein

Eric Rubinstein

Université Paris Cité

Publications: 19

Takahiro Ochiya

Takahiro Ochiya

Tokyo Medical University

Publications: 19

Dieter Kabelitz

Dieter Kabelitz

Kiel University

Publications: 19

Jean-Jacques Fournié

Jean-Jacques Fournié

Federal University of Toulouse Midi-Pyrénées

Publications: 17

Something went wrong. Please try again later.